165 related articles for article (PubMed ID: 37249586)
1. Association of sociodemographic characteristics with utilization of sentinel lymph node biopsy for American Joint Committee on Cancer 8th edition T1b cutaneous melanoma.
Zheng DX; Ahmed FA; Levoska MA; Tripathi R; Mulligan KM; Cwalina TB; Bordeaux JS; Ruiz ES; Rothermel LD; Hoehn RS; Scott JF
Arch Dermatol Res; 2023 Nov; 315(9):2697-2701. PubMed ID: 37249586
[TBL] [Abstract][Full Text] [Related]
2. Should Sentinel Lymph Node Biopsy Be Performed for All T1b Melanomas in the New 8
Egger ME; Stevenson M; Bhutiani N; Jordan AC; Scoggins CR; Philips P; Martin RC; McMasters KM
J Am Coll Surg; 2019 Apr; 228(4):466-472. PubMed ID: 30660817
[TBL] [Abstract][Full Text] [Related]
3. Use and Costs of Sentinel Lymph Node Biopsy in Non-Ulcerated T1b Melanoma: Analysis of a Population-Based Registry.
Herb JN; Ollila DW; Stitzenberg KB; Meyers MO
Ann Surg Oncol; 2021 Jul; 28(7):3470-3478. PubMed ID: 33900501
[TBL] [Abstract][Full Text] [Related]
4. The effect of the AJCC 7th edition change in T1 melanoma substaging on national utilization and outcomes of sentinel lymph node biopsy for thin melanoma.
Hieken TJ; Grotz TE; Comfere NI; Inselman JW; Habermann EB
Melanoma Res; 2015 Apr; 25(2):157-63. PubMed ID: 25647736
[TBL] [Abstract][Full Text] [Related]
5. Health care system and socioeconomic factors associated with variance in use of sentinel lymph node biopsy for melanoma in the United States.
Bilimoria KY; Balch CM; Wayne JD; Chang DC; Palis BE; Dy SM; Lange JR
J Clin Oncol; 2009 Apr; 27(11):1857-63. PubMed ID: 19273706
[TBL] [Abstract][Full Text] [Related]
6. Differences in sentinel lymph node biopsy utilization in eligible melanoma patients treated with Mohs micrographic surgery or wide local excision: A population-based logistic regression model and survival analysis.
Knackstedt TJ
J Am Acad Dermatol; 2023 Apr; 88(4):848-855. PubMed ID: 36368376
[TBL] [Abstract][Full Text] [Related]
7. The importance of mitosis ≥2 in selecting patients with T1 cutaneous melanomas for sentinel lymph node biopsy.
Borgognoni L; Crocetti E; Sestini S; Brandani P; Giannotti V; Gerlini G
Melanoma Res; 2022 Dec; 32(6):469-476. PubMed ID: 36317389
[TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node biopsy guideline concordance in melanoma: Analysis of the National Cancer Database.
Narang J; Hue JJ; Bingmer K; Hardacre JM; Winter JM; Ocuin LM; Ammori JB; Mangla A; Bordeaux J; Rothermel LD
J Surg Oncol; 2021 Sep; 124(4):669-678. PubMed ID: 34109633
[TBL] [Abstract][Full Text] [Related]
9. How does the mitotic index impact patients with T1 melanoma? Comparison between the 7th and 8th edition of the American Joint Committee on Cancer melanoma staging system.
Antonialli AZ; Bertolli E; de Macedo MP; Pinto CAL; Calsavara VF; Neto JPD
An Bras Dermatol; 2020; 95(6):691-695. PubMed ID: 33008658
[TBL] [Abstract][Full Text] [Related]
10. Regional nodal metastasis and 5-year survival in patients with thin melanoma in Queensland: a population-based study.
Theile H; Moore J; Dunn N; Cossio D; Forristal CE; Green AC; Smithers BM
ANZ J Surg; 2020 Apr; 90(4):503-507. PubMed ID: 32162780
[TBL] [Abstract][Full Text] [Related]
11. Utility of a Model for Predicting the Risk of Sentinel Lymph Node Metastasis in Patients With Cutaneous Melanoma.
Marchetti MA; Dusza SW; Bartlett EK
JAMA Dermatol; 2022 Jun; 158(6):680-683. PubMed ID: 35475908
[TBL] [Abstract][Full Text] [Related]
12. Predictors of sentinel lymph node positivity in thin melanoma using the National Cancer Database.
Conic RRZ; Ko J; Damiani G; Funchain P; Knackstedt T; Vij A; Vidimos A; Gastman BR
J Am Acad Dermatol; 2019 Feb; 80(2):441-447. PubMed ID: 30240775
[TBL] [Abstract][Full Text] [Related]
13. Sentinel lymph node biopsy is associated with increased cost in higher risk thin melanoma.
Aiken TJ; Stahl CC; Schwartz PB; Barrett J; Acher AW; Lemaster D; Leverson G; Weber S; Neuman H; Abbott DE
J Surg Oncol; 2021 Jan; 123(1):104-109. PubMed ID: 32939750
[TBL] [Abstract][Full Text] [Related]
14. A nomogram to predict node positivity in patients with thin melanomas helps inform shared patient decision making.
Friedman C; Lyon M; Torphy RJ; Thieu D; Hosokawa P; Gonzalez R; Lewis KD; Medina TM; Rioth MJ; Robinson WA; Kounalakis N; McCarter MD; Gleisner AL
J Surg Oncol; 2019 Dec; 120(7):1276-1283. PubMed ID: 31602665
[TBL] [Abstract][Full Text] [Related]
15. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005).
Chen AY; Halpern MT; Schrag NM; Stewart A; Leitch M; Ward E
J Natl Cancer Inst; 2008 Apr; 100(7):462-74. PubMed ID: 18364506
[TBL] [Abstract][Full Text] [Related]
16. Compliance with sentinel lymph node biopsy guidelines for invasive melanomas treated with Mohs micrographic surgery.
MacArthur KM; Baumann BC; Sobanko JF; Etzkorn JR; Shin TM; Higgins HW; Giordano CN; McMurray SL; Krausz A; Newman JG; Rajasekaran K; Cannady SB; Brody RM; Karakousis GC; Miura JT; Cohen JV; Amaravadi RK; Mitchell TC; Schuchter LM; Miller CJ
Cancer; 2021 Oct; 127(19):3591-3598. PubMed ID: 34292585
[TBL] [Abstract][Full Text] [Related]
17. Sentinel Lymph Node Biopsy Provides Prognostic Value in Thick Head and Neck Melanoma.
Monroe MM; Pattisapu P; Myers JN; Kupferman ME
Otolaryngol Head Neck Surg; 2015 Sep; 153(3):372-8. PubMed ID: 26070510
[TBL] [Abstract][Full Text] [Related]
18. Is sentinel lymph node biopsy the standard of care for cutaneous head and neck melanoma?
Schmalbach CE; Bradford CR
Laryngoscope; 2015 Jan; 125(1):153-60. PubMed ID: 24986770
[TBL] [Abstract][Full Text] [Related]
19. Population-based assessment of sentinel lymph node biopsy in the management of cutaneous melanoma.
Ollek S; Minkova S; Taqi K; Chen L; Martinka M; Davis N; Hamilton T; Stuart H
Can J Surg; 2022; 65(3):E394-E403. PubMed ID: 35701006
[TBL] [Abstract][Full Text] [Related]
20. Trends in Sentinel Lymph Node Biopsy Enactment for Cutaneous Melanoma.
El Sharouni MA; Witkamp AJ; Sigurdsson V; van Diest PJ
Ann Surg Oncol; 2019 May; 26(5):1494-1502. PubMed ID: 30719636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
